Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 211 - 240 of 456
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Amlodipin-Valsartan Stada 5 mg - 80 mg, 5 mg - 160 mg, 10 mg - 160 mg tabletti, kalvopäällysteinen SPC 2022-05-25

PL

Resepti

Amlodipin-Valsartan-Hydrochlorothiazide Orion 5mg-160mg-12.5mg, 5mg-160mg-25mg, 10mg-160mg-12.5mg, 10mg-160mg-25mg, 10mg-320mg-25mg tabletti, kalvopäällysteinen SPC 2023-03-02

PL

Resepti

Amlodipine Vitabalans 5 mg, 10 mg tabletti SPC 2022-01-12

PL

Resepti

Amlodipine-Valsartan-Hydrochlorothiazide Krka 5-160-12.5 mg, 5-160-25 mg, 10-160-12.5 mg, 10-160-25 mg, 10-320-25 mg tabletti, kalvopäällysteinen SPC 2023-08-18

PL

Resepti

Amlodipine-Valsartan-Hydrochlorothiazide Stada 5-160-12.5 mg, 10-160-12.5 mg, 10-320-25 mg tabletti, kalvopäällysteinen SPC 2022-05-25

European Medicines Agency's website:
Amlodipine/Valsartan Mylan - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Amlodipine/Valsartan Mylan - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Amloratio 5 mg, 10 mg tabletti SPC 2022-06-15

European Medicines Agency's website:
Ammonaps - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Amorion 100 mg-ml jauhe oraalisuspensiota varten SPC 2023-02-23

PL

Resepti

Amorion 50 mg-ml jauhe oraalisuspensiota varten SPC 2023-02-23

PL

Resepti

Amorion 500 mg, 750 mg tabletti, kalvopäällysteinen 2023-02-23

PL

Resepti

AMORION COMP 500 mg-125 mg, 875 mg-125 mg tabletti, kalvopäällysteinen SPC 2023-02-23

PL

Resepti

AMORION COMP 500 mg-125 mg, 875 mg-125 mg tabletti, kalvopäällysteinen SPC 2023-02-23

PL

Resepti

Amorion Comp 80 - 11.4 mg-ml jauhe oraalisuspensiota varten SPC 2023-02-23

PL

Resepti

Amoxicillin MIP Pharma 500 mg, 1000 mg tabletti SPC 2023-02-08

PL

Resepti

Amoxicillin Sandoz 500 mg, 750 mg dispergoituva tabletti SPC 2023-03-27

PL

Resepti

Amoxicillin-Clavulanic acid Bioglan 500 mg-125 mg tabletti, kalvopäällysteinen SPC 2024-03-26

PL

Resepti

Amoxicillin-Clavulanic acid Bioglan 875 mg-125 mg tabletti, kalvopäällysteinen SPC 2024-03-26

PL

Resepti

Amoxin 100 mg-ml jauhe oraalisuspensiota varten SPC 2023-04-18

PL

Resepti

Amoxin 500 mg, 750 mg tabletti, kalvopäällysteinen SPC 2023-02-17

PL

Resepti

Amoxin comp 50 mg - 12.5 mg-ml jauhe oraalisuspensiota varten SPC 2023-08-09

PL

Resepti

Amoxin comp 500 mg-125 mg tabletti, kalvopäällysteinen SPC 2023-08-09

PL

Resepti

Amoxin comp 80 mg-11,4 mg-ml jauhe oraalisuspensiota varten SPC 2023-05-08

PL

Resepti

Amoxin comp 875 mg - 125mg kalvopäällysteinen tabletti SPC 2023-08-09

PL

Resepti

Ampicillin/Sulbactam AptaPharma 1 g / 0,5 g, 2 g / 1 g injektio-/infuusiokuiva-aine liuosta varten SPC 2024-06-18

PL

Resepti

Ampikyy 50 mg tabletti SPC 2021-12-29

PL

Resepti

Ampitar 1 g, 2 g, injektio-infuusiokuiva-aine liuosta varten SPC 2023-07-10

PL

Resepti

Ampres 10 mg-ml injektioneste, liuos SPC 2020-07-08.docx

PL

Resepti

Ampres 20 mg-ml injektioneste, liuos SPC 2020-07-08.docx

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  |  Next 30   >